Stryker Corporation (SYK) Financials
SYK Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 39.9 billion | 21.3 billion |
| 2023-09-30 | 38.0 billion | 20.1 billion |
| 2023-06-30 | 37.4 billion | 20.0 billion |
| 2023-03-31 | 36.8 billion | 19.9 billion |
SYK Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 1.4 billion | 40.0 million |
| 2023-09-30 | 902.0 million | 100000 |
| 2023-06-30 | 536.0 million | 200000 |
| 2023-03-31 | 315.0 million | 74.0 million |
SYK Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 1.1 billion |
| 2023-09-30 | 692.0 million |
| 2023-06-30 | 738.0 million |
| 2023-03-31 | 592.0 million |
SYK Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 3.1 billion | - | - |
| 2023-09-30 | 1.9 billion | 10.4 billion | - |
| 2023-06-30 | 1.5 billion | 11.1 billion | - |
| 2023-03-31 | 1.8 billion | 11.9 billion | - |
SYK Shares Outstanding
SYK Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 145.0 million | 350.0 million | 1.9 billion | - |
| 2023-09-30 | 148.0 million | 353.0 million | 1.7 billion | - |
| 2023-06-30 | 152.0 million | 346.0 million | 1.7 billion | - |
| 2023-03-31 | 130.0 million | 339.0 million | 1.8 billion | - |
SYK Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 5.8 billion | 2.1 billion |
| 2023-09-30 | 4.9 billion | 1.8 billion |
| 2023-06-30 | 5.0 billion | 1.8 billion |
| 2023-03-31 | 4.8 billion | 1.8 billion |
SYK
List: Champions
Price: $337.15
Dividend Yield: 0.01%
Forward Dividend Yield: 0.95%
Payout Ratio: 38.79%
Dividend Per Share: 3.20 USD
Earnings Per Share: 8.25 USD
P/E Ratio: 41.46
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Volume: 1.2 million
Ebitda: 881.0 millionMarket Capitalization: 133.1 billion
Average Dividend Frequency: 2
Years Paying Dividends: 32
DGR3: 8.47%
DGR5: 8.92%
DGR10: 9.87%
DGR20: 6.99%